Cost-Effectiveness Analysis of Ranibizumab Biosimilar for Neovascular Age-Related Macular Degeneration in Japan

INTRODUCTION: Neovascular age-related macular degeneration (nAMD) is the world’s leading cause of blindness in elderly people. While anti-vascular endothelial growth factor (VEGF) treatments are used as the first option for patients with nAMD, they are generally expensive and need repeated injection...

Descripción completa

Detalles Bibliográficos
Autores principales: Yanagi, Yasuo, Takahashi, Kanji, Iida, Tomohiro, Gomi, Fumi, Morii, Junko, Kunikane, Eriko, Sakamoto, Taiji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10287869/
https://www.ncbi.nlm.nih.gov/pubmed/37171557
http://dx.doi.org/10.1007/s40123-023-00715-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10287869/
https://www.ncbi.nlm.nih.gov/pubmed/37171557
http://dx.doi.org/10.1007/s40123-023-00715-y

Ejemplares similares